Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Centocor ( CNTO )

No earlier versions found for this Subject.

Return to Centocor ( CNTO )

This company is the next Amgen. Its drug to prevent occlusion of coronary arteries after angioplasty is so good the FDA asked them to
STOP their placebo-controlled trials because the benefits of the drug were so obvious. Formal approval of the drug for this indication is
forthcoming, and the worldwide market is HUGE! They also have a drug
for inflammatory bowel disease in the pipeline and I believe the soon to be announced results will be quite impressive.